Hematologic Neoplasm

2

Review clinical trials related to Hematologic Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Azienda USL Reggio Emilia - IRCCSUpdated: May 11, 2026Locations: 1
Eligibility criteria

Patients with hematologic cancer candidates for HSCT (autologous or allogeneic)... [+2]

Patients or caregivers with comorbidities hindering participation (e.g., signifi...

Status: Recruiting

Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers

Individuals with multiple myeloma (MM) are vulnerable because of the effects of systemic organ damage and the side effects of treatment. A decline in patients' health-related quality of life (HRQoL) and a compromised participation in everyday life was reported. The diagnosis of MM negatively affects the principal informal caregiver. This is a concurrent exploratory mixed methods study that involves the use of a quantitative and a qualitative approach. For the quantitative study, aims are to describe any possible relation between the identified factors with HRQoL and participation in individuals with MM and with reactions to caring and self-efficacy of caregivers. For the qualitative study, aims are to investigate "how" and "why" the disease impacts the daily life of individuals with MM and their caregivers. The final analyses will be based on the comparison of the results of the quantitative phase and the results of the qualitative phase.

Participants needed: 190
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Azienda USL Reggio Emilia - IRCCSUpdated: Aug 29, 2025Locations: 1
Eligibility criteria

diagnosis of MM [+3]

having a loved one (individual with MM) who have participated in the quantitativ... [+3]